The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2016
Filed:
May. 23, 2013
Applicant:
Orion Corporation, Espoo, FI;
Inventors:
Marko Ahlmark, Espoo, FI;
David Din Belle, Espoo, FI;
Mika Kauppala, Helsinki, FI;
Anne Luiro, Helsinki, FI;
Taina Pajunen, Espoo, FI;
Jarmo Pystynen, Espoo, FI;
Eija Tiainen, Espoo, FI;
Matti Vaismaa, Espoo, FI;
Josef Messinger, Espoo, FI;
Assignee:
ORION CORPORATION, Espoo, FI;
Primary Examiner:
Int. Cl.
CPC ...
C07C 205/56 (2006.01); C07C 255/57 (2006.01); C07C 255/53 (2006.01); C07C 255/51 (2006.01); C07C 229/42 (2006.01); C07D 333/60 (2006.01); C07C 255/54 (2006.01); C07D 333/24 (2006.01); C07C 311/29 (2006.01); C07D 207/337 (2006.01); C07D 277/30 (2006.01); C07D 295/192 (2006.01); C07D 213/57 (2006.01); C07D 307/54 (2006.01); C07D 307/80 (2006.01); C07D 309/06 (2006.01); C07D 309/12 (2006.01); C07D 231/12 (2006.01); C07D 231/14 (2006.01); C07D 333/28 (2006.01); C07D 333/70 (2006.01); C07D 277/34 (2006.01); C07D 277/74 (2006.01); C07D 211/14 (2006.01); C07D 295/155 (2006.01); C07D 213/62 (2006.01); C07C 255/59 (2006.01); C07C 309/66 (2006.01); C07C 317/46 (2006.01); C07C 323/62 (2006.01); A61K 31/198 (2006.01); A61K 31/277 (2006.01); A61K 31/341 (2006.01); A61K 31/343 (2006.01); A61K 31/381 (2006.01); A61K 31/382 (2006.01); A61K 31/40 (2006.01); A61K 31/5377 (2006.01); C07C 323/29 (2006.01); C07D 307/81 (2006.01); C07D 309/22 (2006.01);
U.S. Cl.
CPC ...
C07D 333/60 (2013.01); A61K 31/198 (2013.01); A61K 31/277 (2013.01); A61K 31/341 (2013.01); A61K 31/343 (2013.01); A61K 31/381 (2013.01); A61K 31/382 (2013.01); A61K 31/40 (2013.01); A61K 31/5377 (2013.01); C07C 255/53 (2013.01); C07C 255/54 (2013.01); C07C 255/57 (2013.01); C07C 255/59 (2013.01); C07C 309/66 (2013.01); C07C 311/29 (2013.01); C07C 317/46 (2013.01); C07C 323/29 (2013.01); C07C 323/62 (2013.01); C07D 207/337 (2013.01); C07D 211/14 (2013.01); C07D 213/57 (2013.01); C07D 213/62 (2013.01); C07D 231/12 (2013.01); C07D 231/14 (2013.01); C07D 277/30 (2013.01); C07D 277/34 (2013.01); C07D 277/74 (2013.01); C07D 295/155 (2013.01); C07D 295/192 (2013.01); C07D 307/54 (2013.01); C07D 307/80 (2013.01); C07D 307/81 (2013.01); C07D 309/06 (2013.01); C07D 309/12 (2013.01); C07D 309/22 (2013.01); C07D 333/24 (2013.01); C07D 333/28 (2013.01); C07D 333/70 (2013.01);
Abstract
Compounds of formula (I), wherein Ris as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.